Heavy Metals in Ayurvedic Products: Testing Standards and What Consumers Should Know

Dr. Meera Iyer — Wed, 08 Apr 2026 09:00:00 +0000

A 2008 analysis published in JAMA examined 193 Ayurvedic medicines purchased through the internet from manufacturers in the United States and India. Detectable lead, mercury, or arsenic was found in 20.7% of the products. Every metal-containing product exceeded at least one of the daily-intake standards used by the investigators, and several Indian-manufactured rasa shastra products could have supplied lead or mercury at hundreds to thousands of times the cited limits when taken according to their labels. These findings apply to the sampled products rather than to Ayurveda as a whole, but they establish a practical need for ingredient transparency, reliable manufacturing, and batch-specific contaminant testing.

A separate investigation involving users of Ayurvedic products in an Iowa community found that 46 of 115 participants had blood lead concentrations of at least 10 micrograms per decilitre. That value was the investigation’s case threshold, not the current CDC reference value. The CDC now uses 3.5 micrograms per decilitre to identify children with blood lead levels higher than most children’s levels, and it states that this reference value is not a toxicity threshold. No safe blood lead level has been identified for children.

The Two Pathways by Which Metals Enter Ayurvedic Products

Metals may enter an Ayurvedic medicine unintentionally as contaminants or may be deliberately included as named ingredients in a classical herbo-mineral formulation. These situations require different forms of assessment, but neither should be judged from packaging claims alone.

Unintentional Environmental or Manufacturing Contamination

Medicinal plants can acquire arsenic, cadmium, lead, mercury, and other elements from soil, irrigation water, atmospheric deposition, fertilisers, pesticides, storage containers, grinding equipment, or cross-contamination during manufacture. The World Health Organization’s quality-control manual identifies environmental pollution and agricultural practices as possible sources of arsenic and heavy metals in medicinal plant materials. Similar contamination can affect botanical products from any medical tradition.

A 2018 public-health investigation analysed 252 Ayurvedic samples obtained during the investigation of a lead-poisoning cluster. Lead was detected in 65% of those samples, mercury in 38%, and arsenic in 32%. Because the samples were collected in a cluster investigation rather than through random market sampling, those percentages should not be treated as prevalence estimates for all Ayurvedic medicines. They do demonstrate that contaminated and intentionally metal-containing products can occur together within a supply chain.

Intentional Inclusion in Rasa Shastra Formulations

Rasa shastra is the Ayurvedic pharmaceutical discipline in which specified herbs may be combined with processed metals, minerals, salts, or gems. Preparations known as bhasmas are produced through procedures that may include shodhana or preparatory processing, wet trituration with prescribed media known as bhavana, and controlled heating or calcination known as marana. The ingredients and processing sequence differ according to the substance and formula; there is no single cycle count, temperature schedule, or processing medium applicable to every bhasma.

Classical and contemporary formulations may include processed gold (Swarna or Suvarna Bhasma), silver (Rajata Bhasma), iron (Lauha Bhasma), copper (Tamra Bhasma), tin (Vanga Bhasma), lead (Naga Bhasma), mica (Abhraka Bhasma), mercury-containing ingredients such as Parada or Hingula, and arsenic-containing substances such as Hartala and Manahshila. These are not interchangeable with ordinary herbal powders and should not be used without appropriate professional supervision and dependable pharmaceutical quality control.

What Product Surveys Have Established

The 2008 internet-market study distinguished products marketed as rasa shastra medicines from products described as non-rasa-shastra medicines. Detectable lead, mercury, or arsenic occurred in 40.6% of the rasa-shastra products and 17.1% of the others. The rasa-shastra products were therefore about 2.4 times, rather than six times, as likely to contain one or more of the measured elements.

The presence of an element does not by itself establish its source, chemical form, absorption, or clinical effect. Nevertheless, total concentration and the labelled daily dose are essential safety measurements. A product that supplies an excessive daily quantity of lead, mercury, arsenic, or cadmium remains a concern regardless of whether the element entered through soil, manufacturing equipment, substitution, cross-contamination, or deliberate formulation.

Documented poisonings have been associated with Ayurvedic products containing excessive concentrations of toxic elements. Public-health agencies in the United States and Australia have continued to issue warnings about specific imported or unapproved products containing lead, mercury, arsenic, and, in some cases, other undeclared toxic substances. Consumers should act on a warning for the named product and batch rather than assuming that country of origin, price, a “natural” claim, or traditional terminology guarantees quality.

How Regulatory Frameworks Differ

Ayurvedic products may be regulated as medicines, traditional herbal medicines, dietary supplements, complementary medicines, or imported unapproved products, depending on the jurisdiction and the claims made for them. The practical question is not merely whether a country has a numerical metal limit, but which legal category applies to the specific product and what evidence was reviewed before sale.

Jurisdiction	Relevant Framework	What a Consumer Can Check	Important Limitation
United States	Most orally consumed Ayurvedic supplements are sold under the dietary-supplement framework and must comply with applicable FDA labelling and 21 CFR Part 111 manufacturing requirements.	Full Supplement Facts panel, manufacturer identity, lot number, product-level USP or NSF certification, and a batch-specific laboratory report.	FDA generally does not approve dietary supplements before marketing. Facility registration or the phrase “FDA registered” is not product approval or certification.
India	Ayurvedic, Siddha, and Unani medicines are covered by Chapter IVA of the Drugs and Cosmetics Act and the applicable Drugs Rules. Schedule T specifies GMP requirements, while Rule 161 addresses ingredient labelling.	Manufacturer, manufacturing licence details, batch and expiry information, complete ingredients, dosage, required warnings, and a batch Certificate of Analysis.	A GMP licence concerns the manufacturing system; it does not by itself disclose the measured metal content of the purchased batch.
European Union	Herbal medicinal products may require marketing authorisation or traditional-use registration. EMA quality guidance addresses identity, contaminants, microbiology, pesticides, mycotoxins, and toxic metals.	National registration or authorisation details, approved leaflet, labelled composition, and manufacturer.	A food supplement is not evaluated through the same pathway as a registered herbal medicinal product.
United Kingdom	Eligible traditional herbal medicinal products may be registered through the MHRA Traditional Herbal Registration scheme.	A genuine THR number or authorised THR certification mark and the accompanying patient information.	THR confirms required standards for quality, safety, and traditional use; it does not mean that effectiveness was assessed to the standard required for a conventional marketing authorisation.
Australia	Complementary medicines supplied legally are generally entered in the Australian Register of Therapeutic Goods as listed, assessed-listed, or registered medicines.	An AUST L, AUST L(A), or AUST R number on the label and a corresponding ARTG entry.	Unregistered products obtained through overseas websites, personal importation, or informal sellers may fall outside the normal Australian supply controls.

Why a Single “Permissible ppm” Number Is Inadequate

Acceptable specifications depend on the product category, element, daily dose, route of administration, intended duration, applicable pharmacopoeia, and national law. Concentration expressed in parts per million or milligrams per kilogram must be considered together with the quantity consumed each day. Two products with the same concentration can produce different daily exposure when their recommended doses differ greatly.

The WHO manual on medicinal plant materials proposed maximum amounts of 10 milligrams per kilogram for lead and 0.3 milligrams per kilogram for cadmium in dried plant materials. It did not establish a universal four-element limit of 10 ppm lead, 1 ppm mercury, 3 ppm arsenic, and 0.3 ppm cadmium for every herbal medicine, dietary supplement, bhasma, and finished dosage form. A laboratory report should identify the specification used rather than merely stating “within WHO limits.”

Voluntary product-level programmes can provide additional assurance. The USP Verified programme evaluates identity, labelled strength or amount, contaminants such as heavy metals, manufacturing practices, and product performance. NSF/ANSI 173 certification likewise includes label-claim and contaminant requirements. These marks should be verified in the certifier’s current online directory because a facility-level GMP certificate is different from certification of a particular finished product.

Reading the Ingredient List for Metal and Mineral Components

Dosage form alone does not determine whether a product is herbal-only. A churna, vati, gutika, avaleha, asava, arishta, oil, capsule, or tablet may be herbal or may form part of a multi-ingredient preparation. The complete formula and source text or manufacturer’s specification must be examined.

Terms that warrant closer review include:

Bhasma, indicating a specifically processed ash or calcined material.
Parada, Hingula, Rasa Sindura, or related mercury-containing ingredients.
Naga, Vanga, Tamra, Lauha, Mandura, Yashada, Rajata, or Swarna/Suvarna when used as processed metal ingredients.
Hartala, Manahshila, or Gauripashana, which are arsenic-containing mineral substances.
Abhraka, Makshika, and other mineral ingredients requiring substance-specific processing and testing.

A single-herb powder or extract labelled only with a verified botanical species, plant part, and excipients has no declared herbo-metallic ingredient, but it can still contain environmental or manufacturing contaminants. Conversely, familiar formula names should not be classified as safe or hazardous solely from the name because compositions can differ among classical references, proprietary versions, and manufacturers.

How Bhasma Preparation and Testing Should Be Understood

Traditional bhasma manufacture is substance-specific. Processes described in rasa-shastra literature may use repeated purification, grinding, levigation with designated liquids, pellet formation, sealing, and controlled heating. Classical finishing examinations such as nischandratva, rekhapurnatva, varitara, apunarbhava, and niruttha assess characteristics such as absence of metallic lustre, fineness, floating behaviour, and resistance to reversion under specified conditions. They form part of traditional pharmaceutical assessment but do not replace contemporary chemical, microbiological, and toxicological controls.

Instrumental methods answer different questions. Inductively coupled plasma mass spectrometry or optical-emission spectrometry can quantify total elemental content. X-ray diffraction can help identify crystalline phases, while electron microscopy can describe particle size and morphology. Additional methods may be needed to examine chemical speciation, dissolution, bioaccessibility, organic contaminants, microbes, pesticides, and batch-to-batch consistency. A result from one technique should not be presented as proof that a product is nontoxic.

One published characterization reported globular gold-containing particles averaging approximately 56–57 nanometres in a particular Swarna Bhasma sample. Other bhasma analyses have reported different particle sizes, aggregates, and chemical phases. The measurement therefore describes the tested material, not every Swarna Bhasma or all bhasmas. The presence of nanoscale particles is an analytical characteristic rather than an independent guarantee of purity, therapeutic benefit, or safety.

A Practical Consumer Safety Checklist

A responsible purchase should be traceable from the labelled ingredients and lot number to the manufacturer and the results for that production batch. The following checks are more useful than broad claims such as “ancient,” “natural,” “organic,” “laboratory tested,” or “made in an FDA-registered facility.”

Read every ingredient: Confirm the botanical name, plant part, extract ratio where relevant, excipients, and every metal or mineral ingredient. Do not rely only on the front-label product name.
Match the product to its regulatory category: Check the manufacturing licence and required particulars in India, a THR registration in the United Kingdom, an ARTG number in Australia, or applicable dietary-supplement labelling in the United States.
Request a batch-specific Certificate of Analysis: The report should match the lot number and identify the laboratory, test date, method, reporting units, detection or quantification limits, numerical results, and specifications for lead, cadmium, arsenic, and mercury.
Prefer an accredited laboratory: Look for testing performed within the laboratory’s accredited scope, commonly under ISO/IEC 17025. A manufacturer-created summary containing only the word “pass” provides less information than the signed analytical report.
Distinguish product certification from factory certification: GMP is important, but it does not mean that every finished batch has independently passed every contaminant test. Confirm whether a USP or NSF mark applies to the exact product.
Use greater caution with herbo-mineral products: Do not self-prescribe products containing lead-, mercury-, or arsenic-derived ingredients. Obtain them only under the guidance of a qualified Ayurvedic practitioner who can assess the indication, dose, duration, contraindications, and source.
Protect children and pregnancy: Children, fetuses, and pregnant people require particular protection from lead exposure. Discuss all Ayurvedic medicines and supplements with the treating healthcare professional before use.
Keep traceability records: Retain the container, invoice, batch number, expiry date, photographs of the label, and remaining tablets or powder if an adverse event or exposure concern arises.
Check regulator alerts: Search the relevant national regulator’s current safety notices before purchasing an imported product, especially when the seller provides no verifiable manufacturer or batch information.

Quality Control for Herbal-Only Products

Absence of an intentional metal ingredient is only one aspect of botanical quality. Correct identity requires the proper genus, species, plant part, and, where relevant, macroscopic, microscopic, chemical, or chromatographic characteristics. Substitution with a related species, use of the wrong plant part, excessive foreign matter, poor storage, and degradation can change a product even when its metal results are acceptable.

A suitable quality programme may also address pesticides, microbial contamination, aflatoxins or other mycotoxins, residual solvents, foreign matter, and adulterants according to the product and manufacturing process. Consumers should therefore avoid treating a heavy-metal certificate as a complete certificate of safety. It is one important component of identity, purity, strength, and contamination control.

Safety Disclaimer: This article is for educational purposes and does not replace medical diagnosis or treatment. Consult a qualified Ayurvedic practitioner and an appropriate healthcare provider before using any bhasma or herbo-mineral preparation, and before giving an Ayurvedic medicine to a child or using one during pregnancy. Suspected exposure may require blood, urine, or other testing selected according to the element, chemical form, dose, and timing. Contact a healthcare professional or poison-control service promptly after a known high exposure or if abdominal pain, vomiting, weakness, confusion, numbness, tremor, or other neurological symptoms occur. Do not discontinue prescribed medical treatment without professional advice.

Actionable Tip: Select one Ayurvedic product you currently use and compare its lot number with its Certificate of Analysis. Confirm that the document reports actual numerical results for lead, cadmium, arsenic, and mercury, names the analytical method and laboratory, and states the specification applied. When the manufacturer cannot provide a traceable batch report, the ingredients are incomplete, or the product contains a metal or mineral that was not clearly disclosed at purchase, pause further use and seek advice from a qualified practitioner or healthcare provider.

Consumer Safety – Ayurved Healing